Hepatitis B in chronic kidney disease: moving toward effective prevention.
Hepatitis B in chronic kidney disease: moving toward effective prevention.
Control of hepatitis B virus (HBV) infection has been a continuous challenge in the management of patients with advanced kidney disease. HBV infections are still difficult to treat, so the main objective is disease prevention by timely immunization with hepatitis B surface antigen vaccines. In the general population, a simple two- or three-standard-dose vaccination strategy has been proven to be highly successful. In contrast, an intensified and more tailored approach is evolving in patients with advanced renal failure.
Unger JK, Peters H.
Department of Experimental Medicine, Charité Universitätsmedizin Berlin, Berlin, Germany. juliane.unger@charite.de